var data={"title":"Clindamycin (topical): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Clindamycin (topical): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/387893?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=clindamycin-topical-drug-information\" class=\"drug drug_general\">see &quot;Clindamycin (topical): Drug information&quot;</a> and <a href=\"topic.htm?path=clindamycin-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Clindamycin (topical): Patient drug information \t&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008024\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Cleocin;</li>\n      <li>Cleocin-T;</li>\n      <li>Clindacin ETZ;</li>\n      <li>Clindacin Pac;</li>\n      <li>Clindacin-P;</li>\n      <li>Clindagel;</li>\n      <li>ClindaMax [DSC];</li>\n      <li>Clindesse;</li>\n      <li>Evoclin</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008025\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Clinda-T;</li>\n      <li>Clindasol;</li>\n      <li>Clindets;</li>\n      <li>Dalacin T;</li>\n      <li>Dalacin Vaginal</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10533130\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Acne Products</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Antibiotic, Anaerobic</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Antibiotic, Miscellaneous</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10533141\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=clindamycin-topical-drug-information\" class=\"drug drug_general\">see &quot;Clindamycin (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Children, Adolescents, and Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Acne vulgaris:</b> Children &ge;12 years, Adolescents, and Adults: Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gel (Clindagel), Foam (Evoclin): Apply to affected area once daily </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gel (Cleocin T), pledget, lotion, solution: Apply a thin film twice daily </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Bacterial vaginosis:</b> Adolescents and Adults: Intravaginal:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Cream:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">Adolescents: One full applicator inserted intravaginally at bedtime for 7 days (<i>Red Book</i>, 2012)</p>\n    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">Cleocin: One full applicator (100 mg clindamycin) inserted intravaginally once daily before bedtime for 3 or 7 consecutive days in nonpregnant patients and 7 consecutive days in pregnant patients </p>\n    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">Clindesse: One full applicator inserted intravaginally as a single dose at anytime during the day in nonpregnant patients </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Suppository: Insert one ovule (100 mg clindamycin) intravaginally once daily at bedtime for 3 days </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Dosing  adjustment in renal impairment:</b>There are no dosage adjustments provided in the manufacturer's labeling; however, no dosage adjustments are required with systemic clindamycin use. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Dosing adjustment in hepatic impairment:</b>There are no dosage adjustments provided in the manufacturer's labeling; however, no dosage adjustments are required with systemic clindamycin use; use caution with severe hepatic impairment. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008157\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, Vaginal, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin: 2% (40 g) [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindesse: 2% (5 g, 5.8 g [DSC]) [contains disodium edta, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (40 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Foam, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Evoclin: 1% (50 g, 100 g) [contains cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (50 g, 100 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (30 g, 60 g) [contains methylparaben, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindagel: 1% (75 mL) [contains methylparaben, polyethylene glycol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">ClindaMax: 1% (30 g [DSC], 60 g [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin ETZ: 1% [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin Pac: 1% [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (60 mL) [contains cetostearyl alcohol, methylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (30 mL, 60 mL) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (30 mL, 60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suppository, Vaginal, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin: 100 mg (3 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Swab, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (60 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin ETZ: 1% (60 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin-P: 1% (69 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008027\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10533142\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intravaginal: Do not use for topical therapy, instillation in the eye, or oral administration. Wash hands; insert applicator into vagina and expel suppository or cream. Remain lying down for 30 minutes following administration. Wash applicator with soap and water following suppository use; if administering the cream, use each disposable applicator only once. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical foam: Do not use intravaginally. Before applying foam, wash affected area with mild soap, then dry. Do not dispense foam directly onto hands or face. Remove cap, hold can at an upright angle, and dispense foam directly into the cap or onto a cool surface. If can is warm or foam is runny, run can under cold water. Use fingertips to pick up small amounts of foam and gently massage into affected area until foam disappears. Avoid fire, flame, or smoking during or immediately following application. Avoid contact with eyes, mouth, lips, mucous membranes, or broken skin. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical gel, pledget, solution: Do not use intravaginally, instill in the eye, or administer orally. Solution/pledget contains an alcohol base and if inadvertent contact with mucous membranes occurs, rinse with liberal amounts of water. Remove pledget from foil immediately before use; discard after single use. May use more than one pledget for each application to cover area. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical lotion: Shake well immediately before use; apply topically. Do not use intravaginally, instill in the eye, or administer orally.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008075\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream: Store at room temperature. Protect from freezing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Foam: Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Avoid fire, flame, or smoking during or immediately following application.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gel: Store at room temperature.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Clindagel: Do not store in direct sunlight.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lotion: Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Protect from freezing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suppository: Store at room temperature of 25&deg;C (77&deg;F); excursions are permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Avoid heat &gt;30&deg;C (86&deg;F) and high humidity.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pledget: Store at room temperature.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical solution: Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Protect from freezing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10533131\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical: Treatment of acne vulgaris (FDA approved in ages &ge;12 years and adults) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Vaginal:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cleocin Vaginal Cream: Treatment of bacterial vaginosis (FDA approved  in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cleocin Ovules, Clindesse cream: Treatment of bacterial vaginosis (FDA approved in nonpregnant, postmenarchal females)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8007985\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin may be confused with bleomycin, Clinoril, Cubicin, Lincocin</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindamycin may be confused with clarithromycin, Claritin, vancomycin</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindesse may be confused with Clindets [Canada]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008058\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">\n      <b>Topical:</b> Dermatologic: Xeroderma (gel, lotion, solution), oily skin (more common with gel, lotion), erythema (gel, lotion, solution), burning sensation of skin (gel, lotion, solution), exfoliation of skin (lotion, solution), pruritus (gel, lotion, solution)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n      <b>Vaginal:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Pruritus</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Genitourinary: Trichomonal vaginitis, vaginal moniliasis, vaginal pain, vulvovaginal disease, vulvovaginitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Infection: Fungal infection</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Rare but important or life-threatening: Abdominal pain, bacterial infection, colitis, constipation, contact dermatitis, diarrhea (hemorrhagic or severe), dysgeusia, dyspepsia, dysuria, edema, endometriosis, epistaxis, eye pain, flank pain, folliculitis, folliculitis (gram-negative infection), gastrointestinal disease, hypersensitivity reaction, hyperthyroidism, maculopapular rash, menstrual disease, pseudomembranous colitis, pyelonephritis, severe colitis, upper respiratory infection, urinary tract infection, uterine hemorrhage, vulvovaginal pruritus</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008043\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">Hypersensitivity to clindamycin, lincomycin, or any component of the formulation; history of antibiotic-associated colitis, regional enteritis, ulcerative colitis.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008054\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Colitis: Use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD); CDAD has been observed &gt;2 months postantibiotic treatment. Discontinue drug if significant diarrhea, abdominal cramps, or passage of blood and mucus occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Atopic patients: Use with caution in atopic patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Topical foam: Topical foam may cause irritation especially when used with abrasive, desquamating or peeling agents; avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Topical pledget or solution: Topical pledget and topical solution contain an alcohol base and may cause eye irritation or burning. Rinse with cool tap water if product comes in contact with mucous membranes, abraded skin, or eyes. Use caution when applying near mouth (unpleasant taste).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Vaginal products: May weaken condoms, or contraceptive diaphragms; barrier contraceptives are not recommended concurrently or for 3-5 days (depending on the product) following treatment. Vaginal cream contains ingredients that may cause eye burning and irritation; rinse with cool tap water if product comes in contact with the eyes.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>\n        <b>Other warnings/precautions:</b></i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Acne: American Academy of Dermatology (AAD) acne guidelines recommend clindamycin (topical) be used in conjunction with other therapies (<i>not</i> as monotherapy) due to the risk of bacterial resistance. If given for mild acne, clindamycin (topical) should be used in combination with benzoyl peroxide. If given for moderate to severe acne, it should be used in combination with a topical retinoid or systemic antibiotic agent (AAD [Zaenglein 2016]).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26522874\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP, 1997; Shehab, 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299058\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8018207\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=15954&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Systemic): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Topical): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular-Blocking Agents: Clindamycin (Topical) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8018205\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9749572\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;\">Adverse effects were not observed in animal reproduction studies. Clindamycin has been shown to cross the placenta following oral and parenteral dosing (Philipson 1973; Weinstein 1976). The amount of clindamycin available systemically is less following topical and vaginal application than with IV or oral administration.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Various clindamycin vaginal products are available for the treatment of bacterial vaginosis. Recommendations for use in pregnant woman vary by product labeling. Current guidelines note that the same oral or vaginal regimens used in nonpregnant women may be used during pregnancy, including oral or vaginal clindamycin (CDC [Workowski 2015]).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">If treatment for acne is needed during pregnancy, topical clindamycin may be considered if an antibiotic is needed. To decrease systemic exposure, pregnant women should avoid application to inflamed skin for long periods of time, or to large body surface areas (Kong 2013).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10533143\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Observe for changes in bowel frequency.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008079\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis; bacteriostatic or bactericidal depending on drug concentration, infection site, and organism</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008081\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Topical solution or foam, phosphate: Minimal; Vaginal cream, phosphate: ~5%; Vaginal suppository, phosphate: ~30%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Hepatic; forms metabolites (variable activity); Clindamycin phosphate is converted to clindamycin HCl (active)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: Vaginal cream: 1.5 to 2.6 hours following repeated dosing; Vaginal suppository: 11 hours (range: 4 to 35 hours, limited by absorption rate)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Time to peak, serum: Vaginal cream: ~10 to 14 hours (range: 4 to 24 hours); Vaginal suppository: ~5 hours (range: 1 to 10 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (&lt;0.2% with topical foam and solution)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008159\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Cleocin Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (40 g): $230.88</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Clindamycin Phosphate Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (40 g): $108.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Clindesse Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (5 g): $139.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (50 g): $346.74</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Evoclin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (50 g): $571.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $180.53</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Clindagel External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (75 mL): $2,132.71</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $86.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Clindacin ETZ External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (1): $545.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Clindacin Pac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (1): $567.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60 mL): $251.17</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60 mL): $120.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 mL): $87.61</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 mL): $40.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Cleocin Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (3): $210.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $237.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindacin ETZ External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $545.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindacin-P External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (69): $567.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $46.40</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961962\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Acnegon (LK);</li>\n      <li>Albiotin Acne (LK);</li>\n      <li>Aledo Gel (TW);</li>\n      <li>Avocin (KW, QA, SA);</li>\n      <li>Butamycin-N (GR);</li>\n      <li>Chinacin-T (TH);</li>\n      <li>Clearex (SY);</li>\n      <li>Cleocin T (KR, TW);</li>\n      <li>Cleocin-T (BB);</li>\n      <li>Clicia Solution (KR);</li>\n      <li>Clidan (UY);</li>\n      <li>Clidets Gel (MX);</li>\n      <li>Clinagel (BR);</li>\n      <li>Clindac-A (IN);</li>\n      <li>Clindacin (AR, BD, RU);</li>\n      <li>Clindacin T (AE);</li>\n      <li>Clindagel (GR);</li>\n      <li>Clindamycin-T (SA);</li>\n      <li>Clindasol (SA);</li>\n      <li>ClindaTech (PH);</li>\n      <li>Clindax Lotion (BD);</li>\n      <li>Clinderm (PH);</li>\n      <li>Clinex (BD);</li>\n      <li>Cliniderm (LB);</li>\n      <li>Clinika (ID);</li>\n      <li>Clinimycin (KW, QA);</li>\n      <li>Clinimycin T (LB);</li>\n      <li>Clinimycin-T (SA);</li>\n      <li>Clintopic (UY);</li>\n      <li>Clinwas (ES);</li>\n      <li>Cutaclin (CR, DO, GT, HN, MX, NI, PA, PE, SV);</li>\n      <li>Daclin (BD);</li>\n      <li>Dalacin (BE, DK, ES, FI, HU, IS, LU, NO, SI);</li>\n      <li>Dalacin al 1% (VE);</li>\n      <li>Dalacin C Lotion (TR);</li>\n      <li>Dalacin Lotion (AT);</li>\n      <li>Dalacin Solution (AT);</li>\n      <li>Dalacin T (AE, AU, BG, BH, BR, CH, CL, CN, CO, CZ, DK, EE, EG, GB, HK, IE, IT, JO, KW, LV, MT, MX, MY, NL, PE, PK, PL, PT, QA, SA, SG, SK, TH, UA, VN, ZA);</li>\n      <li>Dalacin T Gel (CR, DO, HN, NI, PA, SV);</li>\n      <li>Dalacine (FR);</li>\n      <li>Dalacine T (FR);</li>\n      <li>Derma T (KW, QA);</li>\n      <li>Derma-T (AE, SA);</li>\n      <li>Dermabel (CL);</li>\n      <li>Duoclin (KR);</li>\n      <li>Edason Cutaneous (MT);</li>\n      <li>Glencin T (AE);</li>\n      <li>Kolincin (HK);</li>\n      <li>Lindamax (BD);</li>\n      <li>Medacin T (LB);</li>\n      <li>Mediacin T (AE);</li>\n      <li>Mediklin (ID);</li>\n      <li>Rosil (TH);</li>\n      <li>T3 Mycin Gel (VN);</li>\n      <li>T3-Mycin (ET);</li>\n      <li>T3Mycin (HK, PH, SG);</li>\n      <li>Tidact Gel (MY);</li>\n      <li>Topicil (SG);</li>\n      <li>Zindaclin (BE, CZ, ES, GB, HK, IE, IL, LB, MY, PL, PT, TR);</li>\n      <li>Zindacline (FR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics (AAP). In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. <i>Red Book: 2012 Report of the Committee on Infectious Diseases</i>. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). 2010 STD Treatment Guidelines, 2010. <i>MMWR Recomm Rep</i>. 2010;59(RR-12):1-110. Available at <a href=\"http://www.cdc.gov/std/treatment/2010/%20\" target=\"_blank\">http://www.cdc.gov/std/treatment/2010/ </a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/21160459/pubmed\" target=\"_blank\" id=\"21160459\">21160459</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. <i>Drugs</i>. 2013;73(8):779-787.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/23657872 /pubmed\" target=\"_blank\" id=\"23657872 \">23657872 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Philipson A, Sabath LD, and Charles D, &quot;Transplacental Passage of Erythromycin and Clindamycin,&quot; <i>N Engl J Med</i>, 1973, 288(23):1219-21.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/4700555/pubmed\" target=\"_blank\" id=\"4700555\">4700555</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Weinstein AJ, Gibbs RS, and Gallagher M, &quot;Placental Transfer of Clindamycin and Gentamicin in Term Pregnancy,&quot; <i>Am J Obstet Gynecol</i>, 1976, 124(7):688-91.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/943947/pubmed\" target=\"_blank\" id=\"943947\">943947</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Workowski KA, Bolan GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. <i>MMWR Recomm Rep</i>. 2015;64(RR-03):1-137.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 15954 Version 164.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F8008024\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F8008025\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F10533130\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F10533141\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F8008157\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F8008027\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F10533142\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F8008075\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F10533131\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F8007985\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F8008058\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F8008043\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F8008054\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26522874\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299058\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F8018207\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F8018205\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F9749572\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F10533143\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F8008079\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F8008081\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F8008159\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961962\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/15954|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=clindamycin-topical-drug-information\" class=\"drug drug_general\">Clindamycin (topical): Drug information</a></li><li><a href=\"topic.htm?path=clindamycin-topical-patient-drug-information\" class=\"drug drug_patient\">Clindamycin (topical): Patient drug information \t</a></li></ul></div></div>","javascript":null}